About Medicine OnLine Medicine OnLine Home PageCancer LibrariesDoseCalc OnlineOncology News
Cancer ForumsMedline SearchCancer LinksGlossary

Guide And Atlas For The Detection Of Minimal Residual Disease In AML
References

  1. Sandberg AA, Chen Z. Cancer cytogenetics and molecular genetics: clinical implications (review). Int J Oncol. 1995;7:1241-1251.
  2. Keating MJ, Smith TL, Kantarjian H, et al. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. Leukemia. 1988;2(7):403-412.
  3. Schiffer CA, Lee EJ, Tomiyasu T, et al. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood. 1989;73(1):263-270.
  4. Data on file, Pharmacia & Upjohn Company, Kalamazoo, Mich.
  5. LoCoco F, DeRossi G, Pasqualetti D, et al. CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity. Br J Haematol. 1989;73:480-485.
  6. Miller WH Jr, Levine K, DeBlasio A, et al. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA. Blood. 1993;82(6):1689-1694.
  7. Warrell RP Jr, Frankel SR, Miller WH Jr, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Eng J Med. 1991;324(20):1385-1393.
  8. Maruyama F, Stass SA, Estey EH, et al. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia. 1994;8(1):40-45.
  9. Kusec R, Laczika K, Knöbl P, et al. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia. 1994;8(5):735-739.
  10. Mufti GJ, Flandrin G, Schaefer H-E, et al. An Atlas of Malignant Haematology. London: Martin Dunitz Ltd; 1996; 7, 14, 16, 106, 172.

  11. Shurtleff SA, Meyers S, Hiebert SW, et al. Heterogeneity in CBFß/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16) (p13;q22) in acute myelogenous leukemia. Blood. 1995;85(12):3695-3703.
  12. von Lindern M, Fornerod M, van Baal S, et al. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol. 1992(12)1687-1697.
  13. Nucifora G, Begy CR, Erickson P, et al. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proc Natl Acad Sci USA. 1993;90:7784-7788.
  14. Klinger HP, ed. Human gene mapping 11. Cytogenet Cell Genet (Basel). 1991;58(1-4):25,51.
  15. Thirman MJ, Levitan DA, Kobayashi H, et al. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA. 1994;91:12110-12114.
  16. Greer JP, Kinney MC. Acute nonlymphocytic leukemia. In: Lee GR, Bithell TC, Foerster J, et al, eds. Wintrobeís Clinical Hematology. 9th ed. Philadelphia, Pa: Lea & Febiger;1993:1920-1945.
  17. Berman E, Heller G, Santorsa J, et al. Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood. 1991;77(8):1666-1674.
  18. Vogler WR, Velez-Garcia E, Weiner RS, et al. A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group study. J Clin Oncol. 1992;10(7):1103-1111.
  19. Wiernik PH, Banks PLC, Case DC Jr, et al. Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia. Blood. 1992;79(2):313-319.

Top - Leukemia Library Index - Detection Guide Index

About Medicine OnLine Medicine OnLine Home PageCancer LibrariesDoseCalc OnlineOncology News
Cancer ForumsMedline SearchCancer LinksGlossary